NIH Director Nominee Collins May Push Translational Medicine Into Spotlight
Executive Summary
Francis Collins' intellectual agility and experience working on huge initiatives with a lot of moving parts - the human genome project comes to mind - will serve him well as the National Institutes of Health's director
You may also be interested in...
NIH Rare Diseases Project Could Have Broad Effect On Personalized Medicine
In a high profile effort to speed along personalized medicine, the heads of the National Institutes of Health and FDA are pointing out the possible commercial applications of seemingly small steps, such as the potential for an NIH initiative to accelerate development of therapies for rare diseases to advance personalized medicine in more common illnesses
NIH Rare Diseases Project Could Have Broad Effect On Personalized Medicine
In a high profile effort to speed along personalized medicine, the heads of the National Institutes of Health and FDA are pointing out the possible commercial applications of seemingly small steps, such as the potential for an NIH initiative to accelerate development of therapies for rare diseases to advance personalized medicine in more common illnesses
Orphans Wanted: FDA Offers New Ideas For Rare Disease Drug Development
FDA's top review managers have a message for drug developers: they are eager to find creative ways to work with sponsors to bring new treatments for rare diseases to market